Journal: Journal of Cachexia, Sarcopenia and Muscle
Article Title: Transcriptional Intermediary Factor 1γ–Induced Irisin in Skeletal Muscle Attenuates Renal Fibrosis in Diabetic Nephropathy
doi: 10.1002/jcsm.13810
Figure Lengend Snippet: Effect of TIF1γ on palmitate treatment in C2C12 cells and the paracrine effect of TIF1γ‐induced irisin on palmitate‐treated HK‐2 cells. (A) Changes in irisin, TIF1γ, PGC‐1α and pAkt expression following palmitate (100 μM) treatment in the presence or absence of TIF1γ (2 μg). (B) Changes in irisin secretion following palmitate (100 μM) treatment with or without TIF1γ (2 μg). (C) Changes in EMT markers in palmitate (100 μM)‐treated HK‐2 cells induced by CM from TIF1γ‐transfected C2C12 cells. (D) Western blot analysis of FNDC5 protein levels in C2C12 cells transfected with control or FNDC5‐specific siRNAs (#1–5) for 48 h. (E) Irisin levels in CM from C2C12 cells transfected with 25 nmol siRNA‐FNDC5 and 2 μg TIF1γ, measured by ELISA. (F) Changes in EMT markers in palmitate (100 μM)‐treated HK‐2 cells induced by CM from C2C12 cells transfected with 25 nmol siRNA‐FNDC5 and TIF1γ. Each protein expression level was normalized to α‐tubulin or β‐actin (A, C, D, F). TIF1γ, transcriptional intermediary factor 1γ; HK‐2, human kidney 2 cells; C2C12, murine myoblast cells; PGC‐1α, peroxisome proliferator‐activated receptor gamma coactivator 1‐alpha; pAkt, phosphorylated protein kinase B; EMT, epithelial–mesenchymal transition; BMP‐7, bone morphogenetic protein 7; α‐SMA, alpha‐smooth muscle actin; pSmad2/3, phosphorylated Smad2/3; CM, conditioned medium; siRNA, signal interfering RNA.
Article Snippet: The C2C12 mouse skeletal muscle myoblasts were purchased from the American Type Culture (ATCC, USA).
Techniques: Expressing, Transfection, Western Blot, Control, Enzyme-linked Immunosorbent Assay